DK0750506T3 - Bredspektrede, antimikrobielle forbindelser og fremgangsmåder til anvendelse af disse - Google Patents

Bredspektrede, antimikrobielle forbindelser og fremgangsmåder til anvendelse af disse

Info

Publication number
DK0750506T3
DK0750506T3 DK95909556T DK95909556T DK0750506T3 DK 0750506 T3 DK0750506 T3 DK 0750506T3 DK 95909556 T DK95909556 T DK 95909556T DK 95909556 T DK95909556 T DK 95909556T DK 0750506 T3 DK0750506 T3 DK 0750506T3
Authority
DK
Denmark
Prior art keywords
indolicidin
methods
survival
growth
provides
Prior art date
Application number
DK95909556T
Other languages
English (en)
Inventor
Michael E Selsted
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of DK0750506T3 publication Critical patent/DK0750506T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK95909556T 1994-02-16 1995-02-10 Bredspektrede, antimikrobielle forbindelser og fremgangsmåder til anvendelse af disse DK0750506T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/197,205 US5547939A (en) 1991-06-14 1994-02-16 Broad spectrum antimicrobial compounds and methods of use
PCT/US1995/001895 WO1995022338A1 (en) 1994-02-16 1995-02-10 Broad spectrum antimicrobial compounds and methods of use

Publications (1)

Publication Number Publication Date
DK0750506T3 true DK0750506T3 (da) 2001-05-07

Family

ID=22728460

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95909556T DK0750506T3 (da) 1994-02-16 1995-02-10 Bredspektrede, antimikrobielle forbindelser og fremgangsmåder til anvendelse af disse

Country Status (14)

Country Link
US (1) US5547939A (da)
EP (1) EP0750506B1 (da)
JP (2) JP3147904B2 (da)
AT (1) ATE200426T1 (da)
AU (1) AU683725B2 (da)
CA (1) CA2179286C (da)
DE (1) DE69520668T2 (da)
DK (1) DK0750506T3 (da)
ES (1) ES2155518T3 (da)
GR (1) GR3036092T3 (da)
IL (1) IL112641A (da)
PT (1) PT750506E (da)
WO (1) WO1995022338A1 (da)
ZA (1) ZA951276B (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885965A (en) * 1991-11-01 1999-03-23 Periodontix, Inc. Anti-fungal D-amino acid histatin-based peptides
US5646119A (en) * 1991-11-01 1997-07-08 Periodontix, Inc. D-amino acid histatin-based peptides as anti-fungal and anti-bacterial agents
US6191254B1 (en) * 1995-08-23 2001-02-20 University Of British Columbia Antimicrobial cationic peptides
WO1998006419A1 (en) * 1996-08-15 1998-02-19 Southern Illinois University Enhancement of antimicrobial peptide activity by metal ions
US6180604B1 (en) * 1996-08-21 2001-01-30 Micrologix Biotech Inc. Compositions and methods for treating infections using analogues of indolicidin
EP1174439B1 (en) * 1996-08-21 2008-10-08 Migenix Inc. Compositions and methods for treating infections using analogues of indolicidin
US6503881B2 (en) * 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
WO1999043357A1 (en) * 1998-02-25 1999-09-02 Micrologix Biotech Inc. Indolicidin and cationic peptides conjugated with polymers
SE9801495D0 (sv) * 1998-04-28 1998-04-28 Astra Ab Protein formulationa
US6303575B1 (en) 1998-05-12 2001-10-16 The Regents Of The University Of California Indolicidin analogs and methods of using same
WO1999065506A2 (en) * 1998-06-12 1999-12-23 Micrologix Biotech Inc. Cancer therapy with indolicidin or cationic peptides and their polymer conjugates
US6444645B1 (en) * 1998-06-18 2002-09-03 The Regents Of The University Of California Crosslink-stabilized indolicidin analogs
GB9818938D0 (en) * 1998-08-28 1998-10-21 Alpharma As Bioactive peptides
US6096225A (en) * 1998-09-11 2000-08-01 Nalco Chemical Company Method of controlling biofouling in aqueous media using antimicrobial emulsions
JP2002530274A (ja) * 1998-10-30 2002-09-17 インターリンク・バイオテクノロジーズ・リミテッド・ライアビリティ・カンパニー プロテアーゼ分解に対する安定性の高いペプチド
US6335318B1 (en) 1999-05-10 2002-01-01 The Regents Of The University Of California Antimicrobial theta defensins and methods of using same
US6482799B1 (en) * 1999-05-25 2002-11-19 The Regents Of The University Of California Self-preserving multipurpose ophthalmic solutions incorporating a polypeptide antimicrobial
GB0005702D0 (en) * 2000-03-09 2000-05-03 Alpharma As Method
WO2001062956A1 (en) * 2000-02-25 2001-08-30 Smithkline Beecham Corporation Methods of screening for antimicrobial compounds
GB0005703D0 (en) * 2000-03-09 2000-05-03 Alpharma As Compounds
EP1280772A2 (en) * 2000-04-26 2003-02-05 Wisconsin Alumni Research Foundation Triaryl cation antibiotics from environmental dna
US6835536B2 (en) 2001-08-21 2004-12-28 Micrologix Biotech Inc. Antimicrobial cationic peptides and formulations thereof
US8933029B2 (en) * 2001-08-24 2015-01-13 Carrus Capital Corporation Antimicrobial and anti-inflammatory peptides
DE60335101D1 (de) * 2002-04-25 2011-01-05 Toagosei Co Ltd Antimikrobielles polypeptid und nutzung davon
US7119070B2 (en) * 2002-04-30 2006-10-10 The Regents Of The University Of California Antimicrobial theta defensins, analogs thereof, and methods of use
US20030040032A1 (en) * 2002-08-23 2003-02-27 Demarsh Peter L. Methods of screening for antimicrobial compounds
WO2005049819A1 (ja) * 2003-10-29 2005-06-02 Toagosei Co., Ltd. 抗菌ペプチド及びその利用
JP4507080B2 (ja) * 2004-07-30 2010-07-21 東亞合成株式会社 抗菌ペプチド及びその利用
JP4730584B2 (ja) * 2004-12-06 2011-07-20 東亞合成株式会社 抗菌ペプチド及びその利用
US20080255052A1 (en) * 2004-12-23 2008-10-16 The Regents Of The University Of California Immunologic regulation by theta defensins
US20090030179A1 (en) * 2005-02-15 2009-01-29 Toagosei Co., Ltd Antimicrobial peptide and use thereof
ES2497441T3 (es) 2006-08-21 2014-09-22 The University Of British Columbia Péptidos inmunomoduladores catiónicos pequeños
US8784659B2 (en) * 2007-08-08 2014-07-22 General Electric Company Method for controlling microbial biofilm in aqueous systems
US20110052655A1 (en) * 2007-08-08 2011-03-03 Wilson Kurt Whitekettle Methods and vesicles for controlling protozoa
US7824557B2 (en) * 2007-08-08 2010-11-02 General Electric Company Method for controlling microbial biofilm in aqueous systems
US7785478B2 (en) * 2007-08-08 2010-08-31 General Electric Company Method for controlling protozoa that harbor bacteria
US11918624B2 (en) 2020-06-10 2024-03-05 Kelsius Laboratories LLC Therapeutic composition for use in the treatment of COVID-19 and other cytokine storm associated disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543252A (en) * 1982-01-21 1985-09-24 The Regents Of The University Of California Cationic oligopeptides having microbicidal activity
US5324716A (en) * 1991-06-14 1994-06-28 Regents Of The University Of California Broad spectrum antimicrobial compounds and methods of use

Also Published As

Publication number Publication date
US5547939A (en) 1996-08-20
WO1995022338A1 (en) 1995-08-24
JPH09509175A (ja) 1997-09-16
PT750506E (pt) 2001-09-28
AU683725B2 (en) 1997-11-20
DE69520668D1 (de) 2001-05-17
JP3147904B2 (ja) 2001-03-19
CA2179286A1 (en) 1995-08-24
IL112641A (en) 2000-07-26
ATE200426T1 (de) 2001-04-15
EP0750506A1 (en) 1997-01-02
IL112641A0 (en) 1995-05-26
CA2179286C (en) 1999-09-21
GR3036092T3 (en) 2001-09-28
EP0750506A4 (en) 1998-10-14
JP2001172297A (ja) 2001-06-26
AU1747895A (en) 1995-09-04
DE69520668T2 (de) 2001-09-06
ES2155518T3 (es) 2001-05-16
EP0750506B1 (en) 2001-04-11
ZA951276B (en) 1995-10-23

Similar Documents

Publication Publication Date Title
DK0750506T3 (da) Bredspektrede, antimikrobielle forbindelser og fremgangsmåder til anvendelse af disse
AU9315398A (en) Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response
CA2318398A1 (en) Novel peptides having biological activity
HU9301950D0 (en) Adhesion inhibiting medical preparatives containing cyclic peptides
CS782986A2 (en) Insecticide and method of its active component preparation
ES2178000T3 (es) Composiciones y metodos para tratar infecciones usando analogos de indolicidina.
NO952744L (no) Cytokinbegrensende midler
ES2140082T3 (es) Composiciones peptidicas con actividad de tipo factor de crecimiento.
DK0623144T3 (da) Syntetiske peptider til detoksificering af bakterielle endotoksiner og behandling af septisk shock
KR0180256B1 (en) Bpc peptides, their preparation and use
DE69334146D1 (de) Peptide mit gdp-austauschfaktorartiger wirkung, dafür kodierende nukleinsäuresequenzen, ihre herstellung und verwendung
SE9503679D0 (sv) Antioxidants
BR9407693A (pt) Sequência nucleotídica vetor composiçao farmacêutica utilizaçao do vetor e de um composto
AU3258197A (en) Peptides
WO2001012668A9 (en) Cathelicidin-derived peptides with broad spectrum antimicrobial activity
DE69330268D1 (de) Hämoregulierende peptide
EP0917535A4 (en) NEURO-ACTIVE PEPTIDE
AU2001278884A1 (en) Anti-hiv and anti-tumor peptides and fragments of lysozyme
SE9700301D0 (sv) New compound
GB2283974A (en) Allatostatins and their use
ATE174927T1 (de) Haemoregulatorische penta-oder hexapeptide
ES2127516T3 (es) Peptidos para inhibir la liberacion de pepsina.
WO2003011313A8 (en) Osteogenic growth oligopeptides as stimulants of hematopoiesis
YU8104A (sh) Oligopeptidi osteogenog rasta kao stimulatori hematopoeze
WO1999060117A3 (fr) Polypeptide prax-1